Smartphone app to help older adults with memory problems take blood pressure medicine
Tests a smartphone app for taking hypertension medicines in older adults with mild cognitive impairment.
Key facts
- Who runs it
- University of Arizona
- Where
- Champaign and Tucson, United StatesSee the 2 sites
- Trial code
- Registry title
- bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 29 Feb 2024
- Planned end
- 30 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- bpMedManage
- Record updated
- 15 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for community-living adults aged 60 or older who take blood pressure medicine and notice memory or thinking problems. It tests a smartphone app and education to help them take their medicine.
- Age
- 60 years or older
- Sex
- All sexes can join.
- Disease stage
- Mild memory or thinking problems (mild cognitive impairment). Memory test scores must be TICS-M 27-37 and MoCA 20-26.
- Earlier treatment
- Must manage at least one prescribed blood pressure medicine on their own.
Main reasons for not taking part
- Diagnosis of dementia
- Lives in assisted living or a skilled nursing facility
- History of major depression or other mental health diagnosis
- Other brain or nerve disorder such as stroke, TBI or Parkinson's disease
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age 60+
- Community-dwelling older adults
- Self-reported fluent in English
- Adequate self-reported visual and hearing ability
- Self-reported memory, thinking, or concentration challenges
- Self-manage at least one prescribed antihypertensive medication
- Have and use a smartphone
- No self-reported history of major depression or other mental health diagnoses
- No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
- TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
- Willing to participate in the study for at least 4 months
Who cannot take part
- Diagnosis of dementia
- Lives in assisted living facility or skilled nursing facility
Where in United States
- University of Illinois Urbana-ChampaignChampaign, United StatesContact: Raksha Mudar, PhDTaking people
- University of ArizonaTucson, United StatesContact: Kathleen Insel, PhDTaking people
About the trial
What the trial wants to find out
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
The 2 groups in the trial
- bpMedManage-STreatment being tested
Intervention group will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.
Treatment: bpMedManage
- bpMedManage-PExisting treatment, for comparison
Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.
Treatment: bpMedManage
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
- Plain-language title
- Smartphone app to help older adults with memory problems take blood pressure medicineGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 October 2025